Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85% ...

Kairos Pharma Ltd (NYSE:KAPA) saw its stock jump 165% following the announcement of encouraging safety results from its ongoing Phase 2 clinical trial of ENV-105 in patients battling metastatic ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

A Flinders University study shows that bowel cancer survivors face an elevated risk of developing multiple primary cancers ...

Investing.com -- Kairos Pharma Ltd (NYSE: KAPA) stock surged 165% after the clinical-stage biopharmaceutical company reported positive safety results from its ongoing Phase 2 clinical trial of ENV-105 ...

Kairos Pharma, Ltd. (NYSE American:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces positive safety results from its ongoing Phase 2 ...

Former Sky News presenter Dermot Murnaghan has said he “fell through the gaps” and had a “wake-up call” after receiving his ...

Stage four prostate cancer can mean that the cancer has spread into different parts of the body including nearby body organs, ...

Former Sky News presenter Dermot Murnaghan has said he “fell through the gaps” and had a “wake-up call” after receiving his ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of these men will die of causes ...